Impaired immune surveillance accelerates accumulation of senescent cells and aging.
Ovadya Y, Landsberger T, Leins H, Vadai E, Gal H, Biran A, Yosef R, Sagiv A, Agrawal A, Shapira A, Windheim J, Tsoory M, Schirmbeck R, Amit I, Amit I, Geiger H, Krizhanovsky V. · 2018
Read Impaired immune surveillance accelerates accumulation of senescent cells and aging. by Ovadya Y, Landsberger T, Leins H, Vadai E, Gal H, Biran A, Yosef R, Sagiv A, Agrawal A, Shapira A, Windheim J, Tsoory M, Schirmbeck R, Amit I, Amit I, Geiger H, Krizhanovsky V. (2018) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6303397.txt.
Introduction
Ovadya and co-authors test how immune surveillance limits senescent cells in aging. Their study appeared in Nature Communications. Senescent cells have stopped dividing after damage. They build up in old tissues and can drive decline. The team used mice with weak cell-killing power. These mice lacked the perforin gene.
The mutant mice carried more senescent cells in their tissues. They also showed chronic inflammation and more age-related disorders. Their survival was shorter than normal. A drug that clears senescent cells eased this early aging. The same drug extended life in fast-aging progeroid mice. Results tie immune strength to healthy aging.
Catalog record
| CREATOR | Ovadya Y, Landsberger T, Leins H, Vadai E, Gal H, Biran A, Yosef R, Sagiv A, Agrawal A, Shapira A, Windheim J, Tsoory M, Schirmbeck R, Amit I, Amit I, Geiger H, Krizhanovsky V. |
|---|---|
| YEAR | 2018 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 74 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Impaired immune surveillance accelerates accumulation of senescent cells and aging By Yossi Ovadya, Tomer Landsberger, Hanna Leins, Ezra Vadai, Hilah Gal, Anat Biran, Reut Yosef, Adi Sagiv, Amit Agrawal, Alon Shapira, Joseph Windheim, Michael Tsoory Published in: Nature Communications DOI: 10.1038/s41467-018-07825-3 ABSTRACT Abstract Cellular senescence is a stress response that imposes stable cell-cycle arrest in damaged cells, preventing their propagation in tissues. However, senescent cells accumulate in tissues in advanced age, where they might promote tissue degeneration and malignant transformation. The extent of immune-system involvement in regulating age-related accumulation of senescent cells, and its consequences, are unknown. Here we show that Prf1−/− mice with impaired cell cytotoxicity exhibit both higher senescent-cell tissue burden and chronic inflammation. They suffer from multiple age-related disorders and lower survival. Strikingly, pharmacological elimination of senescent-cells by ABT-737 partially alleviates accelerated aging phenotype in these mice. In LMNA+/G609G progeroid mice, impaired cell cytotoxicity further promotes senescent-cell accumulation and shortens lifespan. ABT-737 administration during the second half of life of these progeroid mice abrogates senescence signature and increases median survival. Our findings shed new light on mechanisms governing senescent-cell presence in aging, and could motivate new strategies for regenerative medicine. INTRODUCTION Aging is characterized by a functional decline in many physiological systems. Both environmental and endogenous stressors, might drive the progression of physiological aging1–3. These include telomere attrition, genomic instability, epigenetic alterations, and loss of proteostasis, each of which damages cells and compromises their functionality3. Cellular senescence, a central component of aging, is a cell-intrinsic stress response programmed to impose stable cell-cycle arrest in damaged cells, thus preventing them from propagating further damage in tissues2,4,5. Normally, a sequence of events leads to the clearance of senescent cells and allows regeneration of the tissues that harbor them6–9. In advanced age, however, the efficiency of this process may be compromised, as suggested by the tendency of senescent cells in the tissues of old individuals to accumulate10,11. This accumulation is reportedly conserved across different species, including rodents12,13, primates14,15, and humans10,11. Under such conditions, the beneficial cell-autonomous role of senescence might be outstripped by a negative impact of senescent cells on other cells, an effect mediated via the senescence-associated secretory phenotype (SASP), which has marked pro-inflammatory characteristics16. Senescent cells are subject to immune surveillance by multiple components of the immune system6–9,17. Senescent cells attract and activate immune cells and serve as highly immunogenic targets for immune clearance. The immune response against senescent cells varies between different pathological conditions. For example, in fibrotic liver senescent cells derived from activated hepatic stellate cells are cleared by natural killer (NK) cells7, whereas senescent pre-malignant hepatocytes are eliminated via the adaptive immune system9. In other pathological conditions, for example in the case of dysplastic nevi, immune clearance does not occur and senescent cells persist for years18. In the context of aging, it is not known to what extent the immune system participates in regulating the number of senescent cells, and whether age-related impairment of immune function contributes to the accumulation of senescent cells in old individuals19. Perforin, a pore-forming protein found in intracellular granules of effector immune cells, is an important mediator of immune cytotoxicity20,21. Upon degranulation, perforin-formed pores enable granzyme penetration and caspase activation to induce apoptosis of the target cell. Perforin-mediated granule exocytosis (but not death-receptor-mediated apoptosis) is essential for the immune surveillance of senescent cells, and disruption of this pathway leads to the accumulation of senescent cells in damaged livers22. To investigate the consequences of impaired immune surveillance of senescent cells in aging, we followed the aging process in mice in which granule-exocytosis-mediated apoptosis was disabled as a result of perforin gene knockout (Prf1−/−)23. Our data indicates that compared to wild-type (WT) mice, Prf1−/− mice accumulates more senescent cells in their tissues with age. The accumulation of senescent cells in these Prf1−/− mice is accompanied by a progressive state of chronic inflammation, followed by increased tissue fibrosis and other types of tissue damage, as well as compromised organ functionality. The poor health of old Prf1−/− mice is associated with fitness reduction, weight loss, kyphosis, older appearance, and shorter lifespan than that of WT controls. These deviant phenotypes were also observed in Prf1−/− mice crossed with progeroid mice. Elimination of senescent cells from old Prf1−/− mice can be achieved by pharmacological inhibitors of the BCL-2 family of proteins, such as ABT-737. This pharmacological approach attenuates age-related phenotypes and gene expression profile in Prf1−/− mice. Finally, implementation of this approach on Prf1−/− progeroid mice increases median lifespan of these mice. RESULTS Perforin deficiency accelerates senescence with age The prevalence of senescent cells in tissues increases with chronological age10,11. While senescent cells are subjected to immune cell cytotoxicity, it is not clear whether age-related impaired cell cytotoxicity could account for their accumulation. To examine this possibility, we set an in vivo experiment for assessment of systemic cytotoxicity of CD8+ T cells in young and old mice. The systemic cytotoxicity of CD8+ T cells in vivo was reduced more then 3-fold (P < 0.01) in aged mice compared to the young ones (Supplementary Figure 1). Age-related decline in cell cytotoxicity was shown to be a consequence of reduced release and binding of perforin at the immunological synapse24. To determine whether immune cell cytotoxicity plays a role in regulation of tissue burden of senescent cells throughout aging, we used Prf1−/− mice, in which immune surveillance of senescent cells is impaired22. We established cohorts of Prf1−/− and control WT mice, both on the background of C57BL/6, and examined selected organs including livers, pancreas, lungs, and skin in 2, 12, and 24-month old mice (defined hereafter as “young”, “adult”, and “old”, respectively). To assess time-dependent accumulation of senescent cells in those tissues, we first assayed them for senescence-associated-β-galactosidase (SA-β-Gal) activity, an assay commonly used to identify senescent cells in tissues and in culture10. We observed an increase in the number of SA-β-Gal + cells with age in all tissues examined. Increase was more pronounced in the Prf1−/− mice (Fig. 1a, b, Supplementary Figure 2a). Quantitative analysis of these cells in WT mice indicated that they comprise around 10% of the examined tissues by the time these mice reach 24 months of age. At the same age in Prf1−/− mice those cells comprised up to 43% of the total cells, demonstrating a significant (P < 0.005) increase of 2- to 4-fold (depending on the tissue) compared to WT mice (Fig. 1b). These finding indicate that tissues of old Prf1−/− mice extensively accumulate SA-β-Gal + cells. [Figure: Old Prf1−/− mice accumulate more senescent cells then old WT mice. Cohorts of Prf1−/− and wild type (WT) C57BL/6 female mice at the age of 2, 12, and 24 months were sacrificed and their livers, pancreas, lungs, and skin were examined for the presence of senescent cells. a SA-β-Gal activity representative frozen sections of livers from 24-months-old mice. Scale bar, 100 µm. b Quantification of cells with marked SA-β-Gal activity, based on Nuclear Fast Red counterstaining, in liver, pancreas, bronchial epithelia, and skin epidermis. (n = 5 mice per group). c Percentages of cells stained positively for p16 in the liver. Values are means ± SEM, (n = 5 mice per group). d Representative images of IHC staining for p16 on liver frozen section.